跳至主要内容
临床试验/DRKS00016531
DRKS00016531已完成未知

Stem cells as an alternative therapy to liver transplantation. A combined experimental study and clinical trial.

Faculty of medicine-Tanta University0 个研究点目标入组 18 人开始时间: 2019年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
45 Years 至 60 Years(—)
性别
All

入选标准

  • All male or female patients aged from 40 to 60 years with evidence of liver decompensation as ascites, low prothrombin time less than 50%, low serum albumin less than 2.5 g/dl, past history of hepatic encephalopathy were included in the study

排除标准

  • Pregnant or lactating females, patients with recent gastrointestinal bleeding (one month), hepatocellular carcinoma, spontaneous bacterial peritonitis, an evidence of human immunodeficiency virus, any life threatening infection, having history of hypersensitivity to G-CSF and those included in any other clinical trials within the previous month were excluded.

研究者

相似试验